Charles River Laboratories | CRL - Creditori Commerciali

Prezzo Delle Azioni
150.85
Cambio Giornaliero
-8.27 -5.20%
Mensile
-14.75%
Annuale
7.01%
Q2 Previsione
147.82




Creditori Commerciali Cambiamento Data
Agilent USD 602M 32M 2025-12
Align Technology USD 123.72M 2.27M 2026-03
Bio-Rad Laboratories USD 133.1M 4.1M 2026-03
Bruker USD 269.1M 53.2M 2026-03
Cardinal Health USD 37.83B 1.16B 2026-03
Charles River Laboratories USD 133.95M 14.85M 2026-03
Cigna USD 9.88B 780M 2026-03
Concord Medical Services Hldg CNY 112.19M 19.4M 2025-06
CVS Health USD 58.59B 795M 2026-03
Danaher USD 1.79B 54M 2026-03
Dentsply International USD 259M 41M 2026-03
Elevance Health USD 6.21B 10.88B 2026-03
Humana USD 6.53B 814M 2026-03
Illumina USD 218M 22M 2026-03
Incyte USD 228.62M 1.41B 2026-03
Intrexon USD 4.85M 3.12M 2024-06
IQVIA Holdings USD 3.64B 112M 2026-03
Laboratory Of America USD 695.7M 145.1M 2026-03
Lakefront Biotherapeutics EUR 95.77M 8.88M 2026-03
Lonza CHF 471M 3M 2024-12
McKesson USD 59.97B 710M 2026-03
Merck EUR 2.11B 182M 2025-12
Mettler Toledo International USD 228.72M 37.91M 2026-03
Novartis USD 4.32B 134M 2026-03
Pfizer USD 4.51B 734M 2026-03
Quest Diagnostics USD 1.5B 100M 2026-03
Revvity USD 169.68M 15.78M 2026-03
Thermo Fisher Scientific USD 3.34B 278M 2026-03
United Therapeutics USD 498.3M 491.2M 2026-03
UnitedHealth USD 77.37B 37.19B 2025-12
Veradigm USD 30.84M 18.23M 2022-12
Waters USD 103.78M 11.95M 2025-12
West Pharmaceutical Services USD 252.3M 1.4M 2026-03